IMMUTEP Ltd Files Form 6-K
Ticker: PRRUF · Form: 6-K · Filed: Sep 23, 2025 · CIK: 1506184
| Field | Detail |
|---|---|
| Company | Immutep Ltd (PRRUF) |
| Form Type | 6-K |
| Filed Date | Sep 23, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, foreign-issuer, regulatory
Related Tickers: IMMU
TL;DR
IMMUTEP Ltd (IMMU) filed a 6-K on 9/22/25. Standard foreign issuer report.
AI Summary
On September 22, 2025, IMMUTEP Ltd filed a Form 6-K. The company, formerly known as Prima BioMed Ltd, is based in Sydney, Australia, and operates in the Pharmaceutical Preparations sector. This filing is a report of a foreign private issuer.
Why It Matters
This filing indicates IMMUTEP Ltd is providing updated information to the SEC as a foreign private issuer, which could be relevant for investors tracking the company's regulatory compliance and disclosures.
Risk Assessment
Risk Level: low — This filing is a routine report for a foreign private issuer and does not contain specific financial or operational news that would inherently increase risk.
Key Numbers
- 001-35428 — SEC File Number (Identifies the company's filing history with the SEC.)
Key Players & Entities
- IMMUTEP Ltd (company) — Registrant
- Prima BioMed Ltd (company) — Former company name
- September 22, 2025 (date) — Filing date
- 001-35428 (other) — SEC File Number
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers that is required to be filed with the SEC whenever the issuer publicly disseminates certain information to its security holders, such as press releases or other material information.
When was IMMUTEP Ltd previously known by another name?
IMMUTEP Ltd was formerly known as Prima BioMed Ltd, with a date of name change on November 19, 2010.
What is IMMUTEP Ltd's primary business sector?
IMMUTEP Ltd operates in the Pharmaceutical Preparations sector, with a Standard Industrial Classification code of [2834].
Where is IMMUTEP Ltd's principal executive office located?
IMMUTEP Ltd's principal executive office is located at Level 32, Australia Square, 264 George Street, Sydney NSW 2000, Australia.
What is the filing date of this Form 6-K?
This Form 6-K was filed on September 22, 2025.
Filing Stats: 261 words · 1 min read · ~1 pages · Grade level 17.6 · Accepted 2025-09-22 21:11:15
Filing Documents
- d76406d6k.htm (6-K) — 10KB
- d76406dex991.htm (EX-99.1) — 11KB
- g76406snap5.jpg (GRAPHIC) — 21KB
- g76406snap6.jpg (GRAPHIC) — 35KB
- 0001193125-25-211928.txt ( ) — 99KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: September 22, 2025 IMMUTEP LIMITED By: /s/ Marc Voigt Name: Marc Voigt Title: Chief Executive Officer